Viewing Study NCT01460693


Ignite Creation Date: 2025-12-25 @ 1:12 AM
Ignite Modification Date: 2026-01-27 @ 6:18 AM
Study NCT ID: NCT01460693
Status: COMPLETED
Last Update Posted: 2018-04-24
First Post: 2010-10-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia
Sponsor: Newcastle University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myeloid Leukemia, Chronic, Chronic Phase View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Myeloid View
None Chronic View
None Chronic-Phase View
None CML View